financetom
Business
financetom
/
Business
/
Former OpenAI chief scientist to start a new AI company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Former OpenAI chief scientist to start a new AI company
Jun 19, 2024 12:22 PM

(Reuters) - ChatGPT maker OpenAI's co-founder and former chief scientist Ilya Sutskever said on Wednesday that he was starting a new artificial intelligence company.

The company is focused on creating a safe AI environment at a time when some of the biggest tech companies are looking to dominate the generative AI boom.

The company is called Safe Superintelligence and is described on its website as an American firm with offices in Palo Alto and Tel Aviv. Sutskever made the announcement revealing that he was starting the company in a post on X.

"Our singular focus means no distraction by management overhead or product cycles, and our business model means safety, security, and progress are all insulated from short-term commercial pressures," the post says.

Sutskever is joined as by former OpenAI researcher Daniel Levy and Daniel Gross, co-founder of Cue and a former AI lead at Apple ( AAPL ) as co-founders of Safe Superintelligence.

Sutskever left Microsoft ( MSFT )-backed OpenAI in May after playing a key role in CEO Sam Altman's dramatic firing and rehiring in November last year. Sutskever was removed from the company's board after Altman returned.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UnitedHealth Lifts Outlook As CEO Promises 'Durable Growth' Ahead
UnitedHealth Lifts Outlook As CEO Promises 'Durable Growth' Ahead
Oct 28, 2025
UnitedHealth Group ( UNH ) stock is trading higher after the insurance mammoth cited a return to sustained growth in its third-quarter 2025 earnings on Tuesday and raised its 2025 guidance. The company reported adjusted earnings of $2.92, down from $7.15 a year ago, beating the consensus of $2.79. Revenues increased 12% year over year to $113.161 billion, slightly edging...
CTS Q3 Adjusted Earnings Fall, Net Sales Rise; 2025 Outlook Revised
CTS Q3 Adjusted Earnings Fall, Net Sales Rise; 2025 Outlook Revised
Oct 28, 2025
08:39 AM EDT, 10/28/2025 (MT Newswires) -- CTS (CTS) reported Q3 adjusted earnings Tuesday of $0.60 per diluted share, down from $0.61 a year earlier. A single analyst polled by FactSet expected $0.61. Net sales for the quarter ended Sept. 30 were $143 million, up from $132.4 million a year earlier. A single analyst surveyed by FactSet expected $136.4 million....
GSK Says European Medicines Agency Grants Orphan Drug Designation for Lung Cancer Therapy
GSK Says European Medicines Agency Grants Orphan Drug Designation for Lung Cancer Therapy
Oct 28, 2025
08:40 AM EDT, 10/28/2025 (MT Newswires) -- GSK (GSK) said Tuesday that its experimental therapy, GSK5764227, for treating pulmonary neuroendocrine carcinoma, a cancer category that includes small-cell lung cancer, has received orphan drug designation from the European Medicines Agency. The drugmaker said the designation is based on early clinical data that showed durable responses in patients in an early-stage trial....
Franklin Electric Q3 Adjusted Earnings, Sales Rise; Updates 2025 EPS Guidance
Franklin Electric Q3 Adjusted Earnings, Sales Rise; Updates 2025 EPS Guidance
Oct 28, 2025
08:39 AM EDT, 10/28/2025 (MT Newswires) -- Franklin Electric ( FELE ) reported Q3 adjusted earnings Tuesday of $1.30 per diluted share, up from $1.17 a year earlier. Analysts polled by FactSet expected $1.31. Net sales for the quarter ended Sept. 30 were $581.7 million, compared with $531.4 million a year earlier. Analysts surveyed by FactSet expected $563.2 million. For...
Copyright 2023-2026 - www.financetom.com All Rights Reserved